''Right again qqqqqq. All these trials are not cheap, so thank God four out of our five gdc trials are funded by others.
Again your right about coming results and on all probability and reasonable will be better which just proves the point again most retail investors cant value a bio stock shown by the recent sell down''
IMO Debating the facts is what HC is about - an investment forum
Who is supplying the study drug at their cost for all these trials - many over 2 years plus for only phase 1 or 2 ???
Who is responsible for the phase 11a trial and all costs and if all goes ahead phase 11b and milestone payments etc... ????
I read about financial grants of $400k and $500k being paid as well - imo capital is precious with the last raise netting only around $3.75m or so after costs
